Prashant Nagpal

22PUBLICATIONS
12CO-AUTHORS
AutoimmunityAstrodynamics and space situational awarenessClinical midwiferyNeurology and neuromuscular diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Nov 14, 2024
Large- and Small-Animal Studies of Safety, Pharmacokinetics, and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target Organs.

Sydney Risen, Sadhana Sharma, Vincenzo S Gilberto

|Sep 19, 2024
Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model.

Sadhana Sharma, Vincenzo S Gilberto, Cassandra L Levens

|Jul 31, 2024
Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids.

Sadhana Sharma, Vincenzo S Gilberto, Jon Rask

|Mar 25, 2024
Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model.

Sadhana Sharma, Sydney Risen, Vincenzo S Gilberto

|Mar 20, 2024
Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders.

Sydney J Risen, Sean W Boland, Sadhana Sharma

|Mar 11, 2024
NF-κB/NLRP3 Translational Inhibition by Nanoligomer Therapy Mitigates Ethanol and Advanced Age-Related Neuroinflammation.

Paige E Anton, Prashant Nagpal, Julie Moreno

Pageof 4

Frequent Collaborators

9 joint publications

Anushree Chatterjee

4 joint publications

Julie Moreno

2 joint publications

Yuchen Ding

1 joint publications

John R Bertram